Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats

Journal of Neuroscience Research

Volumn 79, Issue 3, 2005, Pages 340-350

  Pannu, Ravinder ^a   Barbosa, Ernest ^a   Singh, Avtar K ^a,b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Atorvastatin; Inflammation; SCI

Indexed keywords

ATORVASTATIN; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; CELL LOSS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; FEMALE; GLIOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; LOCOMOTION; NERVE FIBER DEGENERATION; NERVE INJURY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RAT; RATING SCALE; SPINAL CORD INJURY; TISSUE NECROSIS;

ANIMALS; ANTICHOLESTEREMIC AGENTS; DISEASE MODELS, ANIMAL; FEMALE; GLIOSIS; HEPTANOIC ACIDS; INTERLEUKIN-1; MOTOR ACTIVITY; MYELITIS; NECROSIS; NERVE DEGENERATION; NEURONS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OLIGODENDROGLIA; OXIDATIVE STRESS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14044272154     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20345     Document Type: Article

References (77)

1. Balentine JD. 1978. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest 39:236-253.
2. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491.
3. Bartholdi D, Schwab ME. 1995. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 672:177-186.
4. Bartholdi D, Schwab ME. 1997. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9:1422-1438.
5. Basso DM, Beattie MS, Bresnahan JC. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
6. Basso DM, Beattie MS, Bresnahan JC. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256.
7. Bentley D, O'Connor TP. 1994. Cytoskeletal events in growth cone steering. Curr Opin Neurobiol 4:43-48.
8. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. 1998. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 18:3251-3260.
9. Borgens RB, Blight AR, Murphy DJ. 1986. Axonal regeneration in spinal cord injury: a perspective and new technique. J Comp Neurol 250:157-167.
10. Bracken MB. 1990. Methylprednisolone in the management of acute spinal cord injuries. Med J Aust 153:368.
11. Brewer GJ, Wallimann TW. 2000. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 74:1968-1978.
12. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. 1998. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151:77-88.
13. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. 1997. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73-76.
14. David S, Lacroix S. 2003. Molecular approaches to spinal cord repair. Annu Rev Neurosci 26:411-440.
15. Davies SJ, Silver J. 1998. Adult axon regeneration in adult CNS white matter. Trends Neurosci 21:515.
16. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. 1993. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13:2651-2661.
17. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L. 2002. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22:6570-6577.
18. Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ. 2001. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin Cancer Res 7:158-167.
19. Fawcett JW. 1998. Spinal cord repair: from experimental models to human application. Spinal Cord 36:811-817.
20. Fawcett JW, Asher RA. 1999. The glial scar and central nervous system repair. Brain Res Bull 49:377-391.
21. Hamada Y, Ikata T, Katoh S, Tsuchiya K, Niwa M, Tsutsumishita Y, Fukuzawa K. 1996. Roles of nitric oxide in compression injury of rat spinal cord. Free Radic Biol Med 20:1-9.
22. Hayashi M, Ueyama T, Nemoto K, Tamaki T, Senba E. 2000. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 17:203-218.
23. Hsu CY, Dimitrijevic MR. 1990. Methylprednisolone in spinal cord injury: the possible mechanism of action. J Neurotrauma 7:115-119.
24. Hsu CY, Halushka PV, Hogan EL, Cox RD. 1986. Increased thromboxane level in experimental spinal cord injury. J Neurol Sci 74:289-296.
25. Hsu CY, Hogan EL, Gadsden RH Sr, Spicer KM, Shi MP, Cox RD. 1985. Vascular permeability in experimental spinal cord injury. J Neurol Sci 70:275-282.
26. Hsu CY, Liu TH, Xu J, Hogan EL, Chao J, Sun G, Tai HH, Beckman JS, Freeman BA. 1989. Arachidonic acid and its metabolites in cerebral ischemia. Ann N Y Acad Sci 559:282-295.
27. Hurlbert RJ. 2000. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93:1-7.
28. Jaeger CB, Blight AR. 1997. Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair. Exp Neurol 144:381-399.
29. Jin Z, Strittmatter SM. 1997. Rac1 mediates collapsin-1-induced growth cone collapse. J Neurosci 17:6256-6263.
30. Kiernan J. 1990. Interactions between mast cells and nerves. Neurogenic inflammation. Trends Pharmacol Sci 11:316.
31. Kim GM, Xu J, Song SK, Yan P, Ku G, Xu XM, Hsu CY. 2001. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J Neurosci 21:6617-6625.
32. Klusman I, Schwab ME. 1997. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 762:173-184.
33. Kronke M, Schutze S, Scheurich P, Meichle A, Hensel G, Thoma B, Kruppa G, Pfizenmaier K. 1990. Tumour necrosis factor signal transduction. Cell Signal 2:1-8.
34. Lassmann H, Wisniewski HM. 1979. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch Neurol 36:490-497.
35. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Bohm M, Schoen FJ, Moskowitz MA, Liao JK. 2000. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 106:15-24.
36. Laufs U, Liao JK. 2000. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med 10:143-148.
37. Lee YB, Yune TY, Baik SY, Shin YH, Du S, Rhim H, Lee EB, Kim YC, Shin ML, Markelonis GJ, Oh TH. 2000. Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp Neurol 166:190-195.
38. Leist M, Fava E, Montecucco C, Nicotera P. 1997. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur J Neurosci 9:1488-1498.
39. Letourneau PC. 1996. The cytoskeleton in nerve growth cone motility and axonal pathfinding. Perspect Dev Neurobiol 4:111-123.
40. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi DW. 1997. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17:5395-5406.
41. Matsuyama Y, Sato K, Kamiya M, Yano J, Iwata H, Isobe K. 1998. Nitric oxide: a possible etiologic factor in spinal cord cavitation. J Spinal Disord 11:248-252.
42. Mitchison T, Kirschner M. 1988. Cytoskeletal dynamics and nerve growth. Neuron 1:761-772.
43. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-55.
44. Nath N, Giri S, Prasad R, Singh AK, Singh I. 2004. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for multiple sclerosis therapy. J Immunol 172:1273-1286.
45. Noble LJ, Wrathall JR. 1987. The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat. Brain Res 424:177-188.
46. Pahan K, Sheikh FG, Namboodiri AM, Singh I. 1997. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100:2671-2679.
47. Pan W, Kastin AJ, Bell RL, Olson RD. 1999. Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury. J Neurosci 19:3649-3655.
48. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ. 1997. Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev 21:603-613.
49. Pan W, Zhang L, Liao J, Csernus B, Kastin AJ. 2003. Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. J Neuroimmunol 134:111-117.
50. Popovich PG. 2000. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog Brain Res 128:43-58.
51. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT. 1999. Depletion of hematogenous macrophages promotes partial hind-limb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158:351-365.
52. Popovich PG, Horner PJ, Mullin BB, Stokes BT. 1996a. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol 142:258-275.
53. Popovich PG, Stokes BT, Whitacre CC. 1996b. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res 45:349-363.
54. Popovich PG, Wei P, Stokes BT. 1997a. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464.
55. Popovich PG, Yu JY, Whitacre CC. 1997b. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein. J Neuropathol Exp Neurol 56:1323-1338.
56. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwanz M. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4:814-821.
57. Rattan R, Giri S, Singh AK, Singh I. 2003. Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha. Free Radic Biol Med 35:1037-1050.
58. Regan RF. 1996. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons. Neurosci Lett 213:9-12.
59. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. 1999. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci 11:3648-3658.
60. Schwab ME, Bartholdi D. 1996. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76:319-370.
61. Sequeira SM, Ambrosio AF, Malva JO, Carvalho AP, Carvalho CM. 1997. Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide. Nitric Oxide 1:315-329.
62. Stanislaus R, Pahan K, Singh AK, Singh I. 1999. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci Lett 269:71-74.
63. Stanislaus R, Singh AK, Singh I. 2001. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res 66:155-162.
64. Stichel CC, Muller HW. 1998. The CNS lesion scar: new vistas on an old regeneration barrier. Cell Tissue Res 294:1-9.
65. Suzuki T, Tatsuoka H, Chiba T, Sekikawa T, Nemoto T, Moriya H, Sakuraba S, Nakaya H. 2001. Beneficial effects of nitric oxide synthase inhibition on the recovery of neurological function after spinal cord injury in rats. Naunyn Schmiedebergs Arch Pharmacol 363:94-100.
66. Taoka Y, Okajima K. 2000. Role of leukocytes in spinal cord injury in rats. J Neurotrauma 17:219-229.
67. Trapp T, Olah L, Holker I, Besselmann M, Tiesler C, Maeda K, Hossmann KA. 2001. GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice. Mol Cell Neurosci 17:883-894.
68. Wada K, Chatzipanteli K, Busto R, Dietrich WD. 1998a. Role of nitric oxide in traumatic brain injury in the rat. J Neurosurg 89:807-818.
69. Wada K, Chatzipanteli K, Kraydieh S, Busto R, Dietrich WD. 1998b. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43:1427-1436.
70. Wang CX, Olschowka JA, Wrathall JR. 1997. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 759:190-196.
71. Weitz-Schmidt G. 2002. Statins as anti-inflammatory agents. Trends Pharmacol Sci 23:482-486.
72. Winton MJ, Dubreuil CI, Lasko D, Leclerc N, McKerracher L. 2002. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neunte outgrowth on inhibitory substrates. J Biol Chem 277:32820-32829.
73. Wong WW, Tan MM, Xia Z, Dimitroulakos J, Minden MD, Penn LZ. 2001. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clin Cancer Res 7:2067-2075.
74. Wrathall JR. 1992. Spinal cord injury models. J Neurotrauma 9(Suppl):129-134.
75. Wrathall JR, Teng YD, Choiniere D. 1996. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 137:119-126.
76. Xu JA, Hsu CY, Liu TH, Hogan EL, Perot PL Jr, Tai HH. 1990. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem 55:907-912.
77. Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS. 2002. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420:78-84.